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The tonic activation of extrasynaptic GABAA receptors by extracellular GABA provides a powerful means of
regulating neuronal excitability. A consistent ﬁnding from studies that have used various models of
temporal lobe epilepsy is that tonic GABAA receptor-mediated conductances are largely preserved in
epileptic brain (in contrast to synaptic inhibition which is often reduced). Tonic inhibition is therefore an
attractive target for antiepileptic drugs. However, the network consequences of a commonly used
approach to augment tonic GABAA receptor-mediated conductances by global manipulation of extracel-
lular GABA are difﬁcult to predict without understanding how epileptogenesis alters the pharmacology
and GABA sensitivity of tonic inhibition, and how manipulation of tonic conductances modulates the
output of individual neurons. Herewe review the current literature on epilepsy-associated changes in tonic
GABAA receptor-mediated signalling, and speculate about possible effects they have at the network level.
This article is part of the Special Issue entitled ‘New Targets and Approaches to the Treatment of
Epilepsy’.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Alterations in inhibition have often been suggested to underpin
the development of epilepsy or the propensity of a brain to have
seizures. Indeed, it is not unusual to see epilepsy and the devel-
opment of epilepsy (epileptogenesis) illustrated as a balance of
inhibition and excitation tipping towards excitation and away from
inhibition. However, there is gathering evidence that this view is
a vast oversimpliﬁcation. Not least, the observation that untreated
animals and humans with epilepsy will often have infrequent
seizures indicates that any tip of the balance must be compensated,
but compensated in a fashion that generates a less stable network.
Although most studies have investigated changes in fast, synaptic
inhibition mediated by the synaptic release of GABA onto post-
synaptic GABAA receptors (GABAARs), there has been a burgeon-
ing interest in the possible role of the effects of extracellular GABA
on high afﬁnity, slowly desensitizing extrasynaptic GABAARs, often
termed “tonic inhibition”.
The diffuse action of GABA through activation of extrasynaptic
GABAARs has long been recognized as an important signalling
mechanism in the peripheral nervous system (Brown, 1979). It was
even postulated that, in the absence of vesicular neurotransmitter
release, GABA can modulate the excitability of unmyelinated ﬁbresx: þ44 20 72785616.
All rights reserved.through transporter-mediated efﬂux from glial cells in sympathetic
ganglia (Bowery et al., 1976). Extra- and perisynaptic GABAARs are
also abundant in the central nervous system (DeBlas et al., 1988;
Somogyi et al., 1989; Nusser et al., 1996, 1998). It was not until mid
90-s, however, that the presence of the tonic GABAAR-mediated
currents was documented in the central nervous system (Otis et al.,
1991; Salin and Prince, 1996; Brickley et al., 1996). Not only were
such currents determined in different cell populations, but also
their functional role as a mechanism of reducing cell excitability
was recognised (Brickley et al., 1996). Since then, this form of
GABAergic signalling through persistently active GABAARs has
attracted considerable attention and has been described in many
brain regions ranging from cortical areas to subcortical structures
(for reviews see: Semyanov et al., 2004; Mody and Pearce, 2004;
Farrant and Nusser, 2005). Being a powerful mechanism regulating
neuronal output, it has been implicated in a variety of cognitive
processes during normal brain function and has been demon-
strated to be involved in the pathophysiology of several neurolog-
ical disorders (Curia et al., 2009; Cope et al., 2009; Clarkson et al.,
2010). Of particular interest in this respect is the role of tonic
inhibition in restraining excessive excitation in epilepsy (e.g.
Maguire et al., 2005). The potential importance of tonic inhibition
in human epilepsy has been emphasized through the observation
that polymorphisms and mutations in genes encoding extra-
synaptic GABAARs are associated with several human epilepsies
(Dibbens et al., 2004; Feng et al., 2006; Eugène et al., 2007),
implying that deﬁcits in tonic GABAAR-mediated signalling have
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inhibition for maintaining normal neuronal and network function
is further underscored by the ﬁnding that mouse mutants lacking
extrasynaptic GABAARs that mediate tonic conductances in the
cerebellum compensate by up-regulating the two-pore-domain Kþ
channel inhibitory conductance. This compensatory mechanism
results in neurons in the knockout mice having an unaltered
response to excitatory synaptic inputs (Brickley et al., 2001).
Conversely, tonic inhibition itself may substitute for the loss of
other membrane conductances (e.g. HCN-mediated conductance)
involved in the regulation of cell excitability (Chen et al., 2010).
However, determining the role of tonically active GABAARs in
epilepsy is not trivial. Although there have been advances in our
understanding of the effects of tonic GABAAR-mediated conduc-
tances on elementary neuronal computations, how these translate
into network behaviour remains poorly understood. In epilepsy, the
situation is further complicated by cell loss, alterations in intrinsic
cell excitability and changes in network connectivity. Here we
review the current developments in the ﬁeld and the emerging
picture, which, unfortunately, is still far from being complete. Due
to the space limitations we will only focus on the changes that are
related to temporal lobe epilepsy.
2. Tonic inhibition in epilepsy
Epilepsy is a disorder characterised by recurrent paroxysms of
excessive network activity. Althoughmultiple mechanisms (such as
changes in intrinsic neuronal properties, formation of excitatory
recurrent connections, neuronal degeneration, etc.) may be
involved in the generation of pathological network activity, there is
strong evidence that dysfunction of GABAergic signalling plays
a critical role in the pathogenesis of epilepsy and the generation of
seizures. Studies using in vitro models of epilepsy in acute rodent
slices have highlighted the importance of feed-forward inhibition
in restraining excitatory drive, so that a breakdown of inhibition is
necessary for seizure propagation (Trevelyan et al., 2006, 2007).
There have been complementary ﬁndings in brain slices from
humans with epilepsy, in which loss of GABAergic inhibition is
observed prior to a seizure (Huberfeld et al., 2011). It is therefore
not surprising that loss of functional inhibition has been linked to
epileptogenesis. Depending on the aetiology this is generally
(although not universally) seen as a loss of interneurons and/or
reduction of the number of the GABAergic synapses on surviving
principal neurons (Cossart et al., 2001; Wittner, 2001; Buckmaster
et al., 2002; Kobayashi and Buckmaster, 2003; Shao and Dudek,
2005; Hunt et al., 2009; Wyeth et al., 2010). Morphological and
functional changes in the hippocampal formation rapidly follow
the epileptogenic insult and may continue for an extended period
of time up to several months or even longer (Sloviter, 1991;
Friedman et al., 1994; Leroy et al., 2004; Pavlov et al., 2011a).
Despite many adaptive and compensatory processes in epileptic
tissue the general consensus is that the net outcome of these
changes is the loss of phasic (synaptic) inhibition.
Correlationbetween themagnitudeof tonic andphasic inhibition
in hippocampal neurons suggests that vesicular GABA release is an
important source of extracellular GABA (Glykys and Mody, 2007).
Therefore, loss of interneurons and/or a reduced number of
GABAergic synapses would be expected to result in an overall
decrease in GABA release, a reduced concentration of GABA in the
extracellular space, and consequently a reduction in tonic inhibition.
However, experimental evidence indicates that, in post-status epi-
lepticus animals (during and beyond the epileptogenic period), tonic
GABAAR-mediated currents are maintained in many hippocampal
neurons including CA1 pyramidal cells, stratum radiatum interneu-
rons and dentate granule cells (Scimemi et al., 2005; Zhang et al.,2007; Goodkin et al., 2008; Rajasekaran et al., 2010). Some studies
have even reported increased tonic inhibition (Scimemi et al., 2005;
Naylor et al., 2005; Zhan andNadler, 2009). Similar results have been
obtained in models of post-traumatic epilepsy that often display
hippocampal pathology and can result in temporal lobe seizures
(D’Ambrosio et al., 2005; Kharatishvili et al., 2006; Swartz et al.,
2006). Unaltered tonic inhibition has been reported in dentate
granule cells following lateral ﬂuid-percussion brain injury (Pavlov
et al., 2011a), or tonic inhibition has been shown to be enhanced
aftercontrolled cortical impact (Mtchedlishvili et al., 2010).Although
there is no control comparator, large tonic GABAAR-mediated
currents are also present in neocortical and dentate neurons from
humans with temporal lobe epilepsy (Scimemi et al., 2006).
Preservation of tonic GABAAR-mediated conductances in the
hippocampus proper and dentate gyrus is, therefore, a consistent
ﬁnding in tissue from epileptic animals/humans [but see (Qi et al.,
2006) for an in vitro neuronal culture model of epileptiform
activity], which makes tonic inhibition an attractive target for
anticonvulsant drugs. However, several questions need to be
addressed in order to turn this treatment approach into an effective
pharmacological tool. How are tonic conductances maintained in
epilepsy in the face of decreased phasic inhibition? Are these tonic
currents mediated by the same GABAAR subtypes as in control
tissue and, therefore, retain their pharmacology? Is GABA uptake
altered in epilepsy? What are the network effects of altering tonic
inhibition in interneurons and pyramidal cells?
3. GABAA receptor plasticity
Epileptogenesis is associated with changes in the expression of
various GABAAR subunits in animal models (e.g. Brooks-Kayal et al.,
1998) and in humans (Loup et al., 2000). Such changes would be
expected to be reﬂected in altered pharmacology of GABAAR-
mediated tonic currents in chronic epilepsy. Although the exact
identity of GABAARs responsible for the generation of tonic
conductances in different cell types is still debated, there is abun-
dant and consistent evidence for the participation of the a5 and
d subunits. Both subunits are present at the extrasynaptic
membranes of cortical and hippocampal neurons where they form
functional a5b2/3g2 and a4b2/3d receptors. While d-containing
GABAARs are exclusively extrasynaptic or perisynaptic (Wei et al.,
2003), a5-containing receptors can also be found at post-synaptic
sites (Serwanski et al., 2006).
The role of these subunits in generating tonic currents has been
demonstrated using knockout mice, the a5 inverse agonist L-
655,708 and d subunit preferring agonists THIP and neurosteroids
(Stell et al., 2003; Caraiscos et al., 2004). In the hippocampus of
control animals a5- and d-containing GABAARs seem to be themain
contributors to tonic conductances in vitro. Indeed, double
knockout mice lacking both subunits display virtually no tonic
GABAAR-mediated currents in CA1 and CA3 pyramidal cells, den-
tate granule cells and molecular layer interneurons (Glykys et al.,
2008). The relative contribution of different GABAAR subtypes to
the generation of tonic currents in the hippocampus varies
depending on the cell type. In pyramidal cells, a5-containing
receptors contribute to w50% of the tonic conductance, whilst in
dentate granule cells, the majority of the tonic current (w70%) is
mediated by d-containing receptors (Glykys et al., 2008). Data from
genetically modiﬁed mice, however, should be interpreted with
caution, as there may be compensatory changes in the expression
of other GABAAR subunits. This is illustrated by the observation
that, although tonic currents in molecular layer interneurons are
almost completely abolished in double knockout mice, neither a5,
nor d deﬁcient animals display attenuated tonic currents in these
cells, suggesting up-regulation of the remaining subunit(s). In
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proportion (w10%) of extrasynaptic receptors on hippocampal
pyramidal neurons lacks both g and d subunits. These Zn2þ-sensi-
tive ab receptors may also contribute to tonic conductances in
hippocampal neurons (Mortensen and Smart, 2006).
GABAARs involved in tonic inhibition display much higher
afﬁnity towards GABA than those that mediate phasic currents, and
thus can detect low levels of the neurotransmitter in the extracel-
lular space (Stell and Mody, 2002; Yeung et al., 2003). The afﬁnity
varies substantially depending on the subunit composition of the
receptor (Böhme et al., 2004). Therefore, the identity of GABAARs
expressed by a neuron will deﬁne how sensitive it is to ambient
GABA, which may ﬂuctuate in vivo depending on physiopatholog-
ical and behavioural state (Bianchi et al., 2003; Vanini et al., 2011).
However, increases in the concentration of extracellular GABA will
recruit different receptor subtypes (those with lower afﬁnities), so
that the relative contribution of different pools of receptors can
change. This fact also confounds direct comparisons between the
results obtained in different laboratories, when different recording
conditions with variable amounts of GABA and/or inhibitors of
GABA transport are added to the perfusion solution to facilitate the
measurement of tonic currents.
What happens to a5- and d-containing GABAARs in chronic
epilepsy?Contrary toexpectations, anddespitepreservationof tonic
GABAAR-mediated currents in chronic epilepsy, the overall expres-
sion of both subunits is down-regulated (although this varies in
different cell types). d subunit expression in dentate granule cells is
reduced following status epilepticus in animal models (Schwarzer
et al., 1997; Tsunashima et al., 1997; Peng et al., 2004; Rajasekaran
et al., 2010), but see (Brooks-Kayal et al., 1998; Goodkin et al.,
2008). The loss of the d-containing GABAARs is apparently accom-
panied by the up-regulation of a4 subunit expression, leading to
increased perisynaptic expression of a4b2/3g2 receptors (Zhang
et al., 2007). Substituting d subunits with g2 in an expression
system renders a4-containing receptors less sensitive to GABA
[there is a 5 fold increase in the EC50 for GABA (Brown et al., 2002)].
Therefore, these epilepsy-induced changes in extrasynaptic GABAAR
composition can provide a mechanism that allows dentate granule
cells to maintain tonic currents provided extracellular GABA
concentrations are greater (Zhang et al., 2007). However, it is less
certainwhetherup-regulationofGABAARswith lowerafﬁnitywould
explain substantially increased tonic currents observed without
supplemented GABA in a similar model (Zhan and Nadler, 2009).
It has also been suggested that the contribution of a5-containing
GABAARs to tonic currents in dentate granule cells is increased
following status epilepticus (Zhan and Nadler, 2009). Indeed,
a slight increase of a5 mRNA level has been reported in these
neurons (Fritschy et al., 1999; Houser and Esclapez, 2003). None-
theless, it is unlikely that such a change can fully compensate for
the loss of the d subunits and would be sufﬁcient to augment tonic
inhibition as reported in electrophysiological studies.
Down-regulation of d subunit has an important consequence for
drug development strategies. The d subunit confers sensitivity of
GABAARs to neurosteroids and hypnotic drug THIP (Gaboxadol),
which act as agonists of such receptors potentiating tonic
conductances (Belelli and Lambert, 2005; Herd et al., 2007). Sup-
porting decreased expression of d subunit-containing GABAARs,
tonic currents in dentate granule cells become insensitive to these
drugs following induction of status epilepticus (Zhang et al., 2007;
Zhan and Nadler, 2009; Rajasekaran et al., 2010). It is worth noting
that other epileptogenic insults (e.g., traumatic brain injury) are not
associated with d subunit down-regulation, and sensitivity of tonic
currents in dentate granule cells to d subunit-targeting drugs is
maintained (Pavlov et al., 2011a). Dentate granule cells in tissue
resected from humans with intractable temporal lobe epilepsy alsodisplayed augmented tonic currents upon application of the
neuroactive steroid THDOC (Scimemi et al., 2006), suggesting that
the pharmacology of tonic currents may vary considerably
depending on the aetiology of the disease.
High levels of a5 subunit expression in CA1eCA3 pyramidal
cells, normally observed in control animals, are substantially
reduced in CA1/CA2 and, to a lesser extent, CA3 regions of epileptic
animals (Schwarzer et al., 1997; Tsunashima et al., 1997; Houser and
Esclapez, 2003). Although these changes may simply reﬂect cell
degeneration, the absence of a L-655,708-sensitive component of
tonic current in surviving pyramidal cells after status epilepticus
strongly supports the loss of a5-containing GABAARs in these
neurons. As this is not compensated by the recruitment of addi-
tional d subunit-containing receptors (Scimemi et al., 2005), it
remains to be determined which receptor subtype(s) substitute for
the loss of a5-containing receptors in epilepsy.
4. Extracellular GABA levels
A possible explanation for the maintained/increased tonic
GABAAR-mediated currents in epileptic tissue is an increase in the
concentration of extracellular GABA. In the face of reduced phasic
inhibition in epilepsy, it is unlikely that such an increase is due to
enhanced synaptic release. Instead, GABA transporters (GATs), the
activity of which determines extracellular GABA concentration, can
be relatively easily reversed under physiological and pathological
conditions (Wu et al., 2003, 2007). There are two main cortical
GABA transporters, GAT1 and GAT3: the former is predominantly
neuronal and is located at presynaptic GABAergic terminals, while
the latter is primarily expressed in glial processes often further
away from synapses (Borden, 1996; Ribak et al., 1996; Minelli et al.,
1996; Conti et al., 2004). Inhibition or genetic ablation of trans-
porters reduces GABA clearance from the extracellular space and
increases tonic GABAAR-mediated currents (Semyanov et al., 2003;
Jensen et al., 2003; Keros and Hablitz, 2005). However, the relative
role of GAT1 and GAT3 in setting the baseline level of GABA may
differ between brain structures. For example, microdialysis data
indicate that inhibition of GAT3 does not affect hippocampal GABA
concentrations when GAT1 transport is intact (Dalby, 2000), whilst
in the thalamus blockade of GAT3 signiﬁcantly increases tonic
conductances indicating a rise in ambient GABA (Cope et al., 2009).
Although there have been reports of compromised expression of
GABA transporters during epileptogenesis (Patrylo et al., 2001),
other studies have found unaltered function of GAT1 in chronically
epileptic animals (Stief et al., 2005). Data from human studies also
demonstrate that GABA transport is largely preserved in epilepsy
(Mathern et al., 1999; Lee et al., 2006). GATs are electrogenic and
GABA transport depends upon voltage and ionic gradients.
However, there is no evidence to suggest that GAT1-mediated
transport is operating in the reverse mode in epilepsy, as its inhi-
bition substantially increases tonic currents in neurons from
chronically epileptic rats (Frahm et al., 2003; Scimemi et al., 2005).
Whether this is also the case for the glial GAT3 transporters, or
whether reversal of the transporters occurs during seizure activity
is not known.
Reversal of GABA transport in certain subpopulations of neurons
or individual cells in epileptic tissue cannot be ruled out. Some
interneurons in chronic epilepsy may become metabolically more
active, express more GAD and have elevated intracellular GABA
concentrations (Esclapez and Houser, 1999). Enhanced expression
of GATs and an increase in GABA synthesis have also been
demonstrated in dentate granule cells in the kainate model of
chronic seizures (Sperk et al., 2003). Intracellular accumulation of
GABAwill favour reversal of the transporters, but the lack of a direct
and accurate measure of intracellular GABA concentrations makes
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sufﬁcient to reverse GABA transport.
It should also be noted that the reversal of GATs is not
a prerequisite for GABA accumulation in the extracellular space.
Depending on the relationship between the level of GABA release
and the capacity of GABA transport a reduction of transporter
activity may be sufﬁcient to increase extracellular GABA. Indeed,
reduced GAT activity without an identiﬁable decrease of GAT1/
GAT3 protein has been documented to potentiate tonic currents in
the cerebellum (Ortinski et al., 2006). It remains to be determined
whether similar changes occur in the epileptic hippocampus or
cortex.
Another yet unexplored mechanism, which may explain per-
sisting tonic inhibition in epilepsy, is transporter-independent
GABA release from glia (Lee et al., 2010). Finally, tonic conduc-
tance due to spontaneously opening GABAARs (Birnir et al., 2000b,
2000a) cannot be ruled out as a potential means of maintaining
tonic conductances in neurons in epilepsy. Although spontaneously
opening channels have been implicated in the generation of tonic
GABAAR-mediated currents in cultured cells (McCartney et al.,
2007), whether they contribute to tonic inhibition in neurons in
situ has not been addressed.
Irrespective of the sources of GABA, the fact that functional,
tonically active GABAARs are maintained in epilepsy makes them
putative targets for anticonvulsant drugs. Therefore, one treatment
approach is to increase extracellular GABA concentration by
inhibiting its uptake or decreasing breakdown thereby activating
extrasynaptic GABAARs and dampening network excitability (Sills,
2003). Unfortunately, strategies that aim to increase the level of
GABA in brain tissue have been disappointing clinically. Moreover,
using this approach can potentially lead to paradoxical pro-
epileptic effects. The reasons for this can be manifold. For
example, even in the absence of GAT-mediated GABA release in the
interictal period, during seizures the rise in extracellular Kþ
concentration to 10e15 mM may be sufﬁcient to cause
depolarisation-induced reverse of neuronal GABA transport. This
can also be facilitated by chronic changes in Cl homeostasis in
epileptic tissue (Cohen et al., 2002; Palma et al., 2006) and/or
gradual build-up of intracellular Cl during excessive network
activity (Glykys et al., 2009). It is also plausible that increased
glutamate uptake by astrocytes in response to massive release of
the neurotransmitter during seizure activity may cause intracel-
lular Naþ accumulation (as a result of co-transport), and thus
trigger the reversal of co-localised glial GABA transporters (Héja
et al., 2009). If such reversal of GABA transport indeed occurs
during excessive neuronal ﬁring then GAT inhibitors may precipi-
tate or aggravate seizures when network activity reaches a certain
level. Compromised GABA transport can therefore have different
effects in the interictal and ictal period (Patrylo et al., 2001).
Furthermore, increased extracellular GABA itself may have
a pro-convulsive action on the epileptic network. As mentioned
earlier, excessive load on the neuronal Cl extrusion mechanism
together with reduced KCC2 function may push the reversal
potential of GABAARs to more depolarised values (for review see
Blaesse et al., 2009), so that GABA becomes excitatory in some
neurons. Although this mechanism has been implicated in epilepsy,
the extent of its contribution to ictogenesis remains to be
determined.
Another, generally ignored, consequence of increasing GABA
concentration is that it can have cell type-speciﬁc effect on
neuronal excitability. Some interneurons, including certain hippo-
campal subtypes, have EGABA(A) more positive than their resting
membrane potential, and therefore GABA depolarises such cells
(Martina et al., 2001; Chavas and Marty, 2003; Vida et al., 2006;
Song et al., 2011). A small rise in extracellular GABA concentrationshas an excitatory action on these interneurons, while higher
concentrations produce inhibition (Song et al., 2011). Additionally,
as mentioned earlier, depending on the subunit composition, the
afﬁnity of GABAARs expressed in different cells may vary. This
would be expected to set a speciﬁc range of GABA concentrations
that exert an excitatory action for each interneuronal subtype. The
ﬁring of interneurons, in which activation of GABAARs does not
produce depolarisation (Verheugen et al., 1999; Martina et al.,
2001), will only be suppressed by elevated GABA. This will disin-
hibit excitatory neurons counteracting reduction of their excit-
ability. Such changes will be reﬂected in the balance between
excitation and inhibition as extracellular GABA ﬂuctuates. It is
apparent that without fully understanding how tonic GABAAR-
mediated conductances affect excitability of individual neurons the
resulting network effect of manipulating extracellular GABA
concentrations in epileptic tissue is hard to predict.
5. GABAAR-mediated tonic currents in shaping neuronal
output
Persistent activation of GABAARs decreases the membrane input
resistance of a neuron and therefore reduces neuronal voltage
response to incoming excitation (i.e. decreases amplitude of the
excitatory post-synaptic potentials) making it less likely that
a neuron ﬁres an action potential. Neurons contribute to informa-
tion transfer and network function through the generation of action
potentials. Each neuron receives excitatory inputs and generates
distinct outputs to reﬂect the input strength. This inputeoutput
(IeO) relationship of a neuron reﬂects the elementary computa-
tion performed by the cell (Silver, 2010). The IeO functions are
usually presented as either frequency, or probability curves
depending on whether the input strength is related to the output
frequency, or the probability of action potential generation. The IeO
relationship can be modiﬁed through a change in gain (slope) or in
offset (threshold). These are equivalent to multiplicative/divisive
and additive/subtractive operations respectively. An important
feature of gain modulation is that it alters the sensitivity of a cell to
a given change in input: the steeper the slope of the IeO curve, the
lesser change in input is required to generate the same change in
the output (Fig. 1A).
Although modelling studies suggest that the presence of
a constant conductance would only change the offset of a neuron
(Holt and Koch, 1997), a study in cerebellar granule cells has
demonstrated that when a neuron is excited by random inputs,
shunting inhibition can also modulate the gain of the IeO curve
through an impact on input variability (Mitchell and Silver, 2003).
Cortical and hippocampal pyramidal cells do not transmit infor-
mation through continuous high frequency ﬁring, and their IeO
relationship are better described by the probability of ﬁring in
response to temporally correlated synaptic inputs (Azouz, 2005;
Carvalho and Buonomano, 2009). In vivo neurons constantly
receive thousands of synaptic inputs. The presence of background
synaptic activity creates voltage variations at the neuronal
membrane and reduces the slope of the IeO function, so that the
transfer function of a neuron responds to a wider range of input
stimuli (Wolfart et al., 2005). A decrease in membrane input
resistance by persistent activation of GABAARs would be expected
to reduce the magnitude of these variations, and therefore should
increase the IeO gain in addition to changing offset. The prediction
from this is that increased extracellular GABA concentrations will
reduce the excitability of neurons and reduce their dynamic range.
Yet, this is not the case. Due to outward rectiﬁcation tonic GABAAR-
mediated conductance in hippocampal CA1 pyramidal neurons has
little inﬂuence on subthreshold noise, only affecting neurons at
spiking threshold. This voltage-dependence of tonic GABAAR-
Fig. 1. (A) The inputeoutput function of a neuron (black curve) can be modulated by
changing its offset (left), or gain (right). Offset modulation is associated with changes in
the activation threshold (q), but preservation of neuronal sensitivity to a given change
in input. In contrast, gain modulation does not affect the threshold, but alters the
sensitivity of a neuron. (B) Epilepsy is associated with the loss of interneurons and
decreased synaptic (phasic) inhibition. This may result in narrower dynamic range of
individual neurons (grey curves) and population as a whole (blue curves) (see Pouille
et al., 2009). Since tonic inhibition is maintained in neurons from epileptic tissue
increasing this parameter will reduce excitability of neurons (i.e. shift the threshold;
dashed curves on the right graph), but will not affect their sensitivity so that the
network will remain unstable and prone to sudden changes in excitatory inputs.
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function as tonic inhibition changes and thus preserves the
dynamic range of a neuron (Pavlov et al., 2009).
In contrast to tonic inhibition, changes in phasic inhibition are
likely to affect the gain of the IeO relationship (Ferrante et al., 2009;
Carvalho and Buonomano, 2009). Moreover, the loss of synaptic
contacts in the feed-forward inhibitory circuits in epilepsy not only
will affect individual IeO characteristics of neurons, but also may
result in a narrower input range, over which the population of cells
can respond (Pouille et al., 2009). In this scenario reduced phasic
inhibitory synaptic activity will make the neuronal network
unstable so that even a small increase in excitation may result in
large numbers of neurons ﬁring, promoting seizure generation.
Increasing tonic inhibition in CA1 pyramidal neurons may efﬁ-
ciently increase the threshold of network activation by offsettingneuronal IeO functions, but since tonic inhibition in these cells does
not affect neuronal gain, it will not prevent the transition into
a hyper-active state once the threshold is reached (Fig. 1B).
6. Concluding remarks
Modulation of GABAergic function remains one of the main
strategies in epilepsy treatment. Preservation of tonic GABAAR-
mediated conductances in various animal models of epilepsy and in
neurons from epileptic human tissue suggests that targeting this
form of inhibition can be used to suppress network excitability and
prevent seizure generation. However, the successful use of this
approach requires a better understanding of epilepsy-induced
changes in the pharmacology of tonic currents in cell types that
comprise the networks involved in the generation of pathological
activity. This knowledge will enable the development of pharma-
cological tools that will selectively increase tonic inhibition of
excitatory cells rather than interneurons. It would be a step forward
from the currently used approach in which extracellular GABA
concentration is increased globally and, therefore, non-speciﬁcally
affects all neurons.
Another factor that limits our ability to control network behav-
iour in epilepsy is the lack of information on how tonic GABAAR-
mediated conductances alter action potential output in different
neuronal populations. This is further complicated by the fact that
GABA’s action in certain neurons may switch from hyperpolarising
to depolarising (Kaila et al., 1997), facilitated by epilepsy-induced
changes in Cl transport mechanism and HCN down-regulation
(Cohen et al., 2002; Shah et al., 2004; Jung et al., 2007; Wierschke
et al., 2010; Pavlov et al., 2011b). The computational consequence
of such a switch for tonic GABAAR-mediated signalling, and ulti-
mately neuronal circuit function, has yet to be determined.
Acknowledgements
This work was supported by Epilepsy Research UK Fellowship
(A0832) to I.P., funding from Medical Research Council (UK) and
European Integrated Project “EPICURE” (EFP6-037315).
References
Azouz, R., 2005. Dynamic spatiotemporal synaptic integration in cortical neurons:
neuronal gain, revisited. J. Neurophysiol. 94, 2785e2796.
Belelli, D., Lambert, J.J., 2005. Neurosteroids: endogenous regulators of the GABA(A)
receptor. Nat. Rev. Neurosci. 6, 565e575.
Bianchi, L., Ballini, C., Colivicchi, M.A., Della Corte, L., Giovannini, M.G., Pepeu, G.,
2003. Investigation on acetylcholine, aspartate, glutamate and GABA extracel-
lular levels from ventral hippocampus during repeated exploratory activity in
the rat. Neurochem. Res. 28, 565e573.
Birnir, B., Eghbali, M., Everitt, A.B., Gage, P.W., 2000a. Bicuculline, pentobarbital and
diazepam modulate spontaneous GABA(A) channels in rat hippocampal
neurons. Br. J. Pharmacol. 131, 695e704.
Birnir, B., Everitt, A.B., Lim, M.S.F., Gage, P.W., 2000b. Spontaneously opening GABA
A channels in CA1 pyramidal neurones of rat hippocampus. J. Membr. Biol. 174,
21e29.
Blaesse, P., Airaksinen, M.S., Rivera, C., Kaila, K., 2009. Cation-chloride cotrans-
porters and neuronal function. Neuron 61, 820e838.
Böhme, I., Rabe, H., Lüddens, H., 2004. Four amino acids in the alpha subunits
determine the gamma-aminobutyric acid sensitivities of GABAA receptor
subtypes. J. Biol. Chem. 279, 35193e35200.
Borden, L.A., 1996. GABA transporter heterogeneity: pharmacology and cellular
localization. Neurochem. Int. 29, 335e356.
Bowery, N.G., Brown, D.A., Collins, G.G., Galvan, M., Marsh, S., Yamini, G., 1976.
Indirect effects of amino-acids on sympathetic ganglion cells mediated through
the release of gamma-aminobutyric acid from glial cells. Br. J. Pharmacol. 57,
73e91.
Brickley, S.G., Cull-Candy, S.G., Farrant, M., 1996. Development of a tonic form of
synaptic inhibition in rat cerebellar granule cells resulting from persistent
activation of GABAA receptors. J. Physiol. 497 (Pt 3), 753e759.
Brickley, S.G., Revilla, V., Cull-Candy, S.G., Wisden, W., Farrant, M., 2001. Adaptive
regulation of neuronal excitability by a voltage-independent potassium
conductance. Nature 409, 88e92.
I. Pavlov, M.C. Walker / Neuropharmacology 69 (2013) 55e6160Brooks-Kayal, A.R., Shumate, M.D., Jin, H., Rikhter, T.Y., Coulter, D.A., 1998. Selective
changes in single cell GABA(A) receptor subunit expression and function in
temporal lobe epilepsy. Nat. Med. 4, 1166e1172.
Brown, N., Kerby, J., Bonnert, T.P., Whiting, P.J., Wafford, K.A., 2002. Pharmacological
characterization of a novel cell line expressing human alpha(4)beta(3)delta
GABA(A) receptors. Br. J. Pharmacol. 136, 965e974.
Brown, D.A., 1979. Extrasynaptic GABA systems. TINS 2, 271e273.
Buckmaster, P.S., Yamawaki, R., Zhang, G.U.O.F., 2002. Axon arbors and synaptic
connections of a vulnerable population of interneurons in the dentate gyrus
in vivo. J. Comp. Neurol. 445, 360e373.
Caraiscos, V.B., Elliott, E.M., You-Ten, K.E., Cheng, V.Y., Belelli, D., Newell, J.G.,
Jackson, M.F., Lambert, J.J., Rosahl, T.W., Wafford, K.A., MacDonald, J.F.,
Orser, B.A., 2004. Tonic inhibition in mouse hippocampal CA1 pyramidal
neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid
type A receptors. Proc. Natl. Acad. Sci. U S A 101, 3662e3667.
Carvalho, T.P., Buonomano, D.V., 2009. Differential effects of excitatory and inhibi-
tory plasticity on synaptically driven neuronal input-output functions. Neuron
61, 774e785.
Chavas, J., Marty, A., 2003. Coexistence of excitatory and inhibitory GABA synapses
in the cerebellar interneuron network. J. Neurosci. 23, 2019e2031.
Chen, X., Shu, S., Schwartz, L.C., Sun, C., Kapur, J., Bayliss, D.A., 2010. Homeostatic
regulation of synaptic excitability: tonic GABA(A) receptor currents replace I(h)
in cortical pyramidal neurons of HCN1 knock-out mice. J. Neurosci. 30,
2611e2622.
Clarkson, A.N., Huang, B.S., Macisaac, S.E., Mody, I., Carmichael, S.T., 2010. Reducing
excessive GABA-mediated tonic inhibition promotes functional recovery after
stroke. Nature 468, 305e309.
Cohen, I., Navarro, V., Clemenceau, S., Baulac, M., Miles, R., 2002. On the origin of
interictal activity in human temporal lobe epilepsy in vitro. Science 298,
1418e1421.
Conti, F., Minelli, A., Melone, M., 2004. GABA transporters in the mammalian
cerebral cortex: localization, development and pathological implications. Brain
Res. Brain Res. Rev. 45, 196e212.
Cope, D.W., Giovanni, G., Di, Fyson, S.J., Orbán, G., Errington, A.C., Lorincz, M.L.,
Gould, T.M., Carter, D., Crunelli, V., 2009. Enhanced tonic GABAA inhibition in
typical absence epilepsy. Nat. Med. 15, 1392e1398.
Cossart, R., Dinocourt, C., Hirsch, J.C., Merchan-Perez, A., Felipe, J., De, Ben-Ari, Y.,
Esclapez, M., Bernard, C., 2001. Dendritic but not somatic GABAergic inhibition
is decreased in experimental epilepsy. Nat. Neurosci. 4, 52e62.
Curia, G., Papouin, T., Séguéla, P., Avoli, M., 2009. Downregulation of tonic
GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 19,
1515e1520.
Dalby, N.O., 2000. GABA-level increasing and anticonvulsant effects of three
different GABA uptake inhibitors. Neuropharmacology 39, 2399e2407.
D’Ambrosio, R., Fender, J.S., Fairbanks, J.P., Simon, E.A., Born, D.E., Doyle, D.L.,
Miller, J.W., 2005. Progression from frontal-parietal to mesial-temporal epilepsy
after ﬂuid percussion injury in the rat. Brain 128, 174e188.
DeBlas, A.L., Vitorica, J., Friedrich, P., 1988. Localization of the GABAA receptor in the
rat brain with a monoclonal antibody to the 57, 000 Mr peptide of the GABAA
receptor/benzodiazepine receptor/Cl channel complex. J. Neurosci. 8,
602e614.
Dibbens, L.M., Feng, H.-J., Richards, M.C., Harkin, L.A., Hodgson, B.L., Scott, D.,
Jenkins, M., Petrou, S., Sutherland, G.R., Scheffer, I.E., Berkovic, S.F.,
Macdonald, R.L., Mulley, J.C., 2004. GABRD encoding a protein for extra- or peri-
synaptic GABAA receptors is a susceptibility locus for generalized epilepsies.
Hum. Mol. Genet. 13, 1315e1319.
Esclapez, M., Houser, C.R., 1999. Up-regulation of GAD65 and GAD67 in remaining
hippocampal GABA neurons. J. Comp. Neurol. 412, 488e505.
Eugène, E., Depienne, C., Baulac, S., Baulac, M., Fritschy, J.M., Guern, E., Le, Miles, R.,
Poncer, J.C., 2007. GABA(A) receptor gamma 2 subunit mutations linked to
human epileptic syndromes differentially affect phasic and tonic inhibition.
J. Neurosci. 27, 14108e14116.
Farrant, M., Nusser, Z., 2005. Variations on an inhibitory theme: phasic and tonic
activation of GABA(A) receptors. Nat. Rev. Neurosci. 6, 215e229.
Feng, H.-J., Kang, J.-Q., Song, L., Dibbens, L., Mulley, J., Macdonald, R.L., 2006. Delta
subunit susceptibility variants E177A and R220H associated with complex
epilepsy alter channel gating and surface expression of alpha4beta2delta
GABAA receptors. J. Neurosci. 26, 1499e1506.
Ferrante, M., Migliore, M., Ascoli, G.A., 2009. Feed-forward inhibition as a buffer of
the neuronal input-output relation. Proc. Natl. Acad. Sci. U S A 106,
18004e18009.
Frahm, C., Stief, F., Zuschratter, W., Draguhn, A., 2003. Unaltered control of extra-
cellular GABA-concentration through GAT-1 in the hippocampus of rats after
pilocarpine-induced status epilepticus. Epilepsy Res. 52, 243e252.
Friedman, L.K., Pellegrini-giampietro, D.E., Sperber, E.F., Bennett, V.L., Moshe, S.L.,
Zukin, R.S., 1994. Kainate-induced status epilepticus alters glutamate and
GABAA receptor gene expression in adult rat hippocampus: an in situ hybrid-
ization study. J. Neurosci. 14, 2697e2707.
Fritschy, J.M., Kiener, T., Bouilleret, V., Loup, F., 1999. GABAergic neurons and
GABA(A)-receptors in temporal lobe epilepsy. Neurochem. Int. 34, 435e445.
Glykys, J., Mody, I., 2007. The main source of ambient GABA responsible for tonic
inhibition in the mouse hippocampus. J. Physiol. 582, 1163e1178.
Glykys, J., Mann, E.O., Mody, I., 2008. Which GABA(A) receptor subunits are
necessary for tonic inhibition in the hippocampus? J. Neurosci. 28, 1421e1426.Glykys, J., Dzhala, V.I., Kuchibhotla, K.V., Feng, G., Kuner, T., Augustine, G.,
Bacskai, B.J., Staley, K.J., 2009. Differences in cortical versus subcortical
GABAergic signaling: a candidate mechanism of electroclinical uncoupling of
neonatal seizures. Neuron 63, 657e672.
Goodkin, H.P., Joshi, S., Mtchedlishvili, Z., Brar, J., Kapur, J., 2008. Subunit-speciﬁc
trafﬁcking of GABA(A) receptors during status epilepticus. J. Neurosci. 28,
2527e2538.
Héja, L., Barabás, P., Nyitrai, G., Kékesi, K.A., Lasztóczi, B., Toke, O., Tárkányi, G.,
Madsen, K., Schousboe, A., Dobolyi, A., Palkovits, M., Kardos, J., 2009. Glutamate
uptake triggers transporter-mediated GABA release from astrocytes. PloS one 4,
e7153.
Herd, M.B., Belelli, D., Lambert, J.J., 2007. Neurosteroid modulation of synaptic and
extrasynaptic GABA(A) receptors. Pharmacol. Ther. 116, 20e34.
Holt, G.R., Koch, C., 1997. Shunting inhibition does not have a divisive effect on ﬁring
rates. Neural Comput. 9, 1001e1013.
Houser, C.R., Esclapez, M., 2003. Downregulation of the alpha5 subunit of the
GABA(A) receptor in the pilocarpine model of temporal lobe epilepsy. Hippo-
campus 13, 633e645.
Huberfeld, G.,Menendez de la Prida, L., Pallud, J., Cohen, I., Le VanQuyen,M., Adam, C.,
Clemenceau, S., Baulac, M., Miles, R., 2011. Glutamatergic pre-ictal discharges
emerge at the transition to seizure inhumanepilepsy.Nat.Neurosci.14, 627e634.
Hunt, R.F., Scheff, S.W., Smith, B.N., 2009. Posttraumatic epilepsy after controlled
cortical impact injury in mice. Exp. Neurol. 215, 243e252.
Jensen, K., Chiu, C.-S., Sokolova, I., Lester, H.A., Mody, I., 2003. GABA transporter-1
(GAT1)-deﬁcient mice: differential tonic activation of GABAA versus GABAB
receptors in the hippocampus. J. Neurophysiol. 90, 2690e2701.
Jung, S., Jones, T.D., Lugo, J.N., Sheerin, A.H., Miller, J.W., D’Ambrosio, R.,
Anderson, A.E., Poolos, N.P., 2007. Progressive dendritic HCN channelopathy
during epileptogenesis in the rat pilocarpine model of epilepsy. J. Neurosci. 27,
13012e13021.
Kaila, K., Lamsa, K., Smirnov, S., Taira, T., Voipio, J., 1997. Long-lasting GABA-medi-
ated depolarization evoked by high-frequency stimulation in pyramidal
neurons of rat hippocampal slice is attributable to a network-driven, bicar-
bonate-dependent Kþ transient. J. Neurosci. 17, 7662e7672.
Keros, S., Hablitz, J.J., 2005. Subtype-speciﬁc GABA transporter antagonists syner-
gistically modulate phasic and tonic GABA a conductances in rat neocortex.
J. Neurophysiol. 94, 2073e2085.
Kharatishvili, I., Nissinen, J.P., McIntosh, T.K., Pitkänen, A., 2006. A model of post-
traumatic epilepsy induced by lateral ﬂuid-percussion brain injury in rats.
Neuroscience 140, 685e697.
Kobayashi, M., Buckmaster, P.S., 2003. Reduced inhibition of dentate granule cells in
a model of temporal lobe epilepsy. J. Neurosci. 23, 2440e2452.
Lee, T.-S., Bjørnsen, L.P., Paz, C., Kim, J.H., Spencer, S.S., Spencer, D.D., Eid, T., de
Lanerolle, N.C., 2006. GAT1 and GAT3 expression are differently localized in the
human epileptogenic hippocampus. Acta Neuropathol. 111, 351e363.
Lee, S., Yoon, B.-E., Berglund, K., Oh, S.-J., Park, H., Shin, H.-S., Augustine, G.J., Lee, C.J.,
2010. Channel-mediated tonic GABA release from glia. Science 330, 790e796.
Leroy, C., Poisbeau, P., Keller, A.F., Nehlig, A., 2004. Pharmacological plasticity of
GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe
epilepsy. J. Physiol. 557, 473e487.
Loup, F., Wieser, H.-G., Yonekawa, Y., Aguzzi, A., Fritschy, J.-M., 2000. Selective
alterations in GABAA receptor subtypes in human temporal lobe epilepsy.
Neuron 20, 5401e5419.
Maguire, J.L., Stell, B.M., Raﬁzadeh, M., Mody, I., 2005. Ovarian cycle-linked changes
in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and
anxiety. Nat. Neurosci. 8, 797e804.
Martina, M., Royer, S., Paré, D., 2001. Cell-type-speciﬁc GABA responses and chloride
homeostasis in the cortex and amygdala. J. Neurophysiol. 86, 2887e2895.
Mathern, G.W., Mendoza, D., Lozada, A., Pretorius, J.K., Dehnes, Y., Danbolt, N.C.,
Nelson, N., Leite, J.P., Chimelli, L., Born, D.E., Sakamoto, A.C., Assirati, J.A., Fried, I.,
Peacock, W.J., Ojemann, G.A., Adelson, P.D., 1999. Hippocampal GABA and
glutamate transporter immunoreactivity in patients with temporal lobe
epilepsy. Neurology 52, 453e472.
McCartney, M.R., Deeb, T.Z., Henderson, T.N., Hales, T.G., 2007. Tonically active
GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-
independent gating. Mol. Pharmacol. 71, 539e548.
Minelli, A., DeBiasi, S., Brecha, N.C., Zuccarello, L.V., Conti, F., 1996. GAT-3, a high-
afﬁnity GABA plasma membrane transporter, is localized to astrocytic
processes, and it is not conﬁned to the vicinity of GABAergic synapses in the
cerebral cortex. J. Neurosci. 16, 6255e6264.
Mitchell, S.J., Silver, R.A., 2003. Shunting inhibition modulates neuronal gain during
synaptic excitation. Neuron 38, 433e445.
Mody, I., Pearce, R.A., 2004. Diversity of inhibitory neurotransmission through
GABA(A) receptors. TINS 27, 569e575.
Mortensen, M., Smart, T.G., 2006. Extrasynaptic alphabeta subunit GABAA receptors
on rat hippocampal pyramidal neurons. J. Physiol. 577, 841e856.
Mtchedlishvili, Z., Lepsveridze, E., Xu, H., Kharlamov, E.A., Lu, B., Kelly, K.M., 2010.
Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells
after traumatic brain injury. Neurobiol. Dis. 38, 464e475.
Naylor, D.E., Liu, H., Wasterlain, C.G., 2005. Trafﬁcking of GABA(A) receptors, loss of
inhibition, and a mechanism for pharmacoresistance in status epilepticus.
J. Neurosci. 25, 7724e7733.
Nusser, Z., Sieghart, W., Benke, D., Fritschy, J.M., Somogyi, P., 1996. Differential
synaptic localization of two major gamma-aminobutyric acid type A receptor
I. Pavlov, M.C. Walker / Neuropharmacology 69 (2013) 55e61 61alpha subunits on hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U S A 93,
11939e11944.
Nusser, Z., Sieghart, W., Somogyi, P., 1998. Segregation of different GABAA receptors
to synaptic and extrasynaptic membranes of cerebellar granule cells.
J. Neurosci. 18, 1693e1703.
Ortinski, P.I., Turner, J.R., Barberis, A., Motamedi, G., Yasuda, R.P., Wolfe, B.B.,
Kellar, K.J., Vicini, S., 2006. Deletion of the GABA(A) receptor alpha1 subunit
increases tonic GABA(A) receptor current: a role for GABA uptake transporters.
J. Neurosci. 26, 9323e9331.
Otis, T.S., Staley, K.J., Mody, I., 1991. Perpetual inhibitory activity in mammalian
brain slices generated by spontaneous GABA release. Brain Res. 545, 142e150.
Palma, E., Amici, M., Sobrero, F., Spinelli, G., Angelantonio, S.D., Ragozzino, D.,
Mascia, A., Scoppetta, C., Esposito, V.,Miledi, R., Eusebi, F., 2006. Anomalous levels
of Cl transporters in the hippocampal subiculum from temporal lobe epilepsy
patients make GABA excitatory. Proc. Natl. Acad. Sci. U S A 103, 8465e8468.
Patrylo, P.R., Spencer, D.D., Williamson, A., Ortinski, P.I., Turner, J.R., Barberis, A.,
Motamedi, G., Yasuda, R.P., Wolfe, B., Kellar, K.J., Vicini, S., Mcnay, E.C.,
Mccrimmon, R.J., Sherwin, R.S., 2001. GABA uptake and heterotransport are
impaired in the dentate gyrus of epileptic rats and humans with temporal lobe
sclerosis. J. Neurophysiol. 85, 1533e1542.
Pavlov, I., Savtchenko, L.P., Kullmann, D.M., Semyanov, A., Walker, M.C., 2009.
Outwardly rectifying tonically active GABAA receptors in pyramidal cells
modulate neuronal offset, not gain. J. Neurosci. 29, 15341e15350.
Pavlov, I., Huusko, N., Drexel, M., Kirchmair, E., Sperk, G., Pitkänen, A., Walker, M.C.,
2011a. Progressive loss of phasic, but not tonic, GABA(A) receptor-mediated
inhibition in dentate granule cells in a model of post-traumatic epilepsy in
rats. Neuroscience 194, 208e219.
Pavlov, I., Scimemi, A., Savtchenko, L., Kullmann, D.M., Walker, M.C., 2011b. I(h)-
mediated depolarization enhances the temporal precision of neuronal inte-
gration. Nat. Commun. 2, 199.
Peng, Z., Huang, C.S., Stell, B.M., Mody, I., Houser, C.R., 2004. Altered expression of
the delta subunit of the GABAA receptor in a mouse model of temporal lobe
epilepsy. J. Neurosci. 24, 8629e8639.
Pouille, F., Marin-Burgin, A., Adesnik, H., Atallah, B.V., Scanziani, M., 2009. Input
normalization by global feedforward inhibition expands cortical dynamic range.
Nat. Neurosci. 12, 1577e1585.
Qi, J.-shun, Yao, J., Fang, C., Luscher, B., Chen, G., 2006. Downregulation of tonic
GABA currents following epileptogenic stimulation of rat hippocampal cultures.
J. Physiol. 577, 579e590.
Rajasekaran, K., Joshi, S., Sun, C., Mtchedlishvilli, Z., Kapur, J., 2010. Receptors with
low afﬁnity for neurosteroids and GABA contribute to tonic inhibition of granule
cells in epileptic animals. Neurobiol. Dis. 40, 490e501.
Ribak, C.E., Tong, W.M., Brecha, N.C., 1996. GABA plasma membrane transporters,
GAT-1 and GAT-3, display different distributions in the rat hippocampus.
J. Comp. Neurol. 367, 595e606.
Salin, A., Prince, A., 1996. Spontaneous GABAA receptor-mediated inhibitory
currents in adult rat somatosensory cortex. J. Neurophysiol. 75, 1573e1588.
Schwarzer, C., Tsunashima, K., Wanzenböck, C., Fuchs, K., Sieghart, W., Sperk, G.,
1997. GABA(A) receptor subunits in the rat hippocampus II: altered distribution
in kainic acid-induced temporal lobe epilepsy. Neuroscience 80, 1001e1017.
Scimemi, A., Semyanov, A., Sperk, G., Kullmann, D.M., Walker, M.C., 2005. Multiple
and plastic receptors mediate tonic GABAA receptor currents in the hippo-
campus. J. Neurosci. 25, 10016e10024.
Scimemi, A., Andersson, A., Heeroma, J.H., Strandberg, J., Rydenhag, B.,
McEvoy, A.W., Thom, M., Asztely, F., Walker, M.C., 2006. Tonic GABA(A)
receptor-mediated currents in human brain. Eur. J. Neurosci. 24, 1157e1160.
Semyanov, A., Walker, M.C., Kullmann, D.M., 2003. GABA uptake regulates cortical
excitability via cell type-speciﬁc tonic inhibition. Nat. Neurosci. 6, 484e490.
Semyanov, A., Walker, M.C., Kullmann, D.M., Silver, R.A., 2004. Tonically active
GABA A receptors: modulating gain and maintaining the tone. TINS 27,
262e269.
Serwanski, D.R., Miralles, C.P., Christie, S.B., Mehta, A.K., Li, X., Blas, A.L.D.E., 2006.
Synaptic and nonsynaptic localization of GABAA receptors containing the
alpha5 subunit in the rat brain. J. Comp. Neurol. 499, 458e470.
Shah, M.M., Anderson, A.E., Leung, V., Lin, X., Johnston, D., 2004. Seizure-induced
plasticity of h channels in entorhinal cortical layer III pyramidal neurons.
Neuron 44, 495e508.
Shao, L.-R., Dudek, F.E., 2005. Changes in mIPSCs and sIPSCs after kainate treatment:
evidence for loss of inhibitory input to dentate granule cells and possible
compensatory responses. J. Neurophysiol. 94, 952e960.
Sills, G.J., 2003. Pre-clinical studies with the GABAergic compounds vigabatrin and
tiagabine. Epileptic Disord. 5, 51e56.Silver, R.A., 2010. Neuronal arithmetic. Nat. Rev. Neurosci. 11, 474e489.
Sloviter, R.S., 1991. Permanently altered hippocampal structure, excitability, and
inhibition after experimental status epilepticus in the rat: the “dormant basket
cell” hypothesis and its possible relevance to temporal lobe epilepsy. Hippo-
campus 1, 41e66.
Somogyi, P., Takagi, H., Richards, J.G., Mohler, H., 1989. Subcellular localization of
benzodiazepine/GABAA receptors in the cerebellum of rat, cat, and monkey
using monoclonal antibodies. J. Neurosci. 9, 2197e2209.
Song, I., Savtchenko, L., Semyanov, A., 2011. Tonic excitation or inhibition is set by
GABA(A) conductance in hippocampal interneurons. Nat. Commun. 2, 376.
Sperk, G., Schwarzer, C., Heilman, J., Furtinger, S., Reimer, R.J., Edwards, R.H.,
Nelson, N., 2003. Expression of plasma membrane GABA transporters but not of
the vesicular GABA transporter in dentate granule cells after kainic acid
seizures. Hippocampus 13, 806e815.
Stell, B.M., Mody, I., 2002. Receptors with different afﬁnities mediate phasic and
tonic GABA(A) conductances in hippocampal neurons. J. Neurosci. 22, RC223.
Stell, B.M., Brickley, S.G., Tang, C.Y., Farrant, M., Mody, I., 2003. Neuroactive steroids
reduce neuronal excitability by selectively enhancing tonic inhibition mediated
by delta subunit-containing GABAA receptors. Proc. Natl. Acad. Sci. U S A 100,
14439e14444.
Stief, F., Piechotta, A., Gabriel, S., Schmitz, D., Draguhn, A., 2005. Functional GABA
uptake at inhibitory synapses in CA1 of chronically epileptic rats. Epilepsy Res.
66, 199e202.
Swartz, B.E., Houser, C.R., Tomiyasu, U., Walsh, G.O., DeSalles, A., Rich, J.R., Delgado-
Escueta, A., 2006. Hippocampal cell loss in posttraumatic human epilepsy.
Epilepsia 47, 1373e1382.
Trevelyan, A.J., Sussillo, D., Watson, B.O., Yuste, R., 2006. Modular propagation of
epileptiform activity: evidence for an inhibitory veto in neocortex. J. Neurosci.
26, 12447e12455.
Trevelyan, A.J., Sussillo, D., Yuste, R., 2007. Feedforward inhibition contributes to the
control of epileptiform propagation speed. J. Neurosci. 27, 3383e3387.
Tsunashima, K., Schwarzer, C., Kirchmair, E., Sieghart, W., Sperk, G., 1997. GABA(A)
receptor subunits in the rat hippocampus III: altered messenger RNA expression
in kainic acid-induced epilepsy. Neuroscience 80, 1019e1032.
Vanini, G., Wathen, B.L., Lydic, R., Baghdoyan, H.A., 2011. Endogenous GABA levels in
the pontine reticular formation are greater during wakefulness than during
rapid eye movement sleep. J. Neurosci. 31, 2649e2656.
Verheugen, J.A., Fricker, D., Miles, R., 1999. Noninvasive measurements of the
membrane potential and GABAergic action in hippocampal interneurons.
J. Neurosci. 19, 2546e2555.
Vida, I., Bartos, M., Jonas, P., 2006. Shunting inhibition improves robustness of
gamma oscillations in hippocampal interneuron networks by homogenizing
ﬁring rates. Neuron 49, 107e117.
Wei, W., Zhang, N., Peng, Z., Houser, C.R., Mody, I., 2003. Perisynaptic localization of
delta subunit-containing GABA(A) receptors and their activation by GABA
spillover in the mouse dentate gyrus. J. Neurosci. 23, 10650e10661.
Wierschke, S., Lehmann, T.-N., Dehnicke, C., Horn, P., Nitsch, R., Deisz, R.A., 2010.
Hyperpolarization-activated cation currents in human epileptogenic neocortex.
Epilepsia 51, 404e414.
Wittner, L., 2001. Preservation of perisomatic inhibitory input of granule cells in the
epileptic human dentate gyrus. Neuroscience 108, 587e600.
Wolfart, J., Debay, D., Masson, G., Le, Destexhe, A., Bal, T., 2005. Synaptic background
activity controls spike transfer from thalamus to cortex. Nat. Neurosci. 8,
1760e1767.
Wu, Y., Wang, W., Richerson, G.B., 2003. Vigabatrin induces tonic inhibition via
GABA transporter reversal without increasing vesicular GABA release.
J. Neurophysiol. 89, 2021e2034.
Wu, Y., Wang, W., Díez-Sampedro, A., Richerson, G.B., 2007. Nonvesicular inhibitory
neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56,
851e865.
Wyeth, M.S., Zhang, N., Mody, I., Houser, C.R., 2010. Selective reduction of
cholecystokinin-positive basket cell innervation in a model of temporal lobe
epilepsy. J. Neurosci. 30, 8993e9006.
Yeung, J.Y.T., Canning, K.J., Zhu, G., Pennefather, P., MacDonald, J.F., Orser, B.A., 2003.
Tonically activated GABAA receptors in hippocampal neurons are high-afﬁnity,
low-conductance sensors for extracellular GABA. Mol. Pharmacol. 63, 2e8.
Zhan, R.-Z., Nadler, J.V., 2009. Enhanced tonic GABA current in normotopic and hilar
ectopic dentate granule cells after pilocarpine-induced status epilepticus.
J. Neurophysiol. 102, 670e681.
Zhang, N., Wei, W., Mody, I., Houser, C.R., 2007. Altered localization of GABA(A)
receptor subunits on dentate granule cell dendrites inﬂuences tonic and phasic
inhibition in a mouse model of epilepsy. J. Neurosci. 27, 7520e7531.
